These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15161071

  • 1. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
    Garmory HS, Freeman D, Brown KA, Titball RW.
    Vaccine; 2004 Feb 25; 22(8):947-57. PubMed ID: 15161071
    [Abstract] [Full Text] [Related]

  • 2. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW.
    Microb Pathog; 1997 Sep 25; 23(3):167-79. PubMed ID: 9281474
    [Abstract] [Full Text] [Related]

  • 3. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE, Butcher WA, Titball RW, Hill J.
    Vaccine; 2007 Oct 16; 25(42):7301-6. PubMed ID: 17869388
    [Abstract] [Full Text] [Related]

  • 4. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C, Lingard B, Flick-Smith HC, Baillie LW, Hill J, Atkins HS.
    Vaccine; 2009 May 11; 27(21):2775-80. PubMed ID: 19366573
    [Abstract] [Full Text] [Related]

  • 5. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A, Roy CJ, Powell BS, Adamovicz JJ, Freytag LC, Clements JD.
    Infect Immun; 2005 Aug 11; 73(8):5256-61. PubMed ID: 16041052
    [Abstract] [Full Text] [Related]

  • 6. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
    Leary SE, Griffin KF, Galyov EE, Hewer J, Williamson ED, Holmström A, Forsberg A, Titball RW.
    Microb Pathog; 1999 Mar 11; 26(3):159-69. PubMed ID: 10089156
    [Abstract] [Full Text] [Related]

  • 7. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A, Cohen S, Levy Y, Halperin G, Lazar S, Velan B, Shafferman A, Flashner Y, Mamroud E.
    Vaccine; 2008 Mar 20; 26(13):1616-25. PubMed ID: 18304706
    [Abstract] [Full Text] [Related]

  • 8. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED, Stagg AJ, Eley SM, Taylor R, Green M, Jones SM, Titball RW.
    Vaccine; 2007 Jan 22; 25(6):1142-8. PubMed ID: 17101198
    [Abstract] [Full Text] [Related]

  • 9. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
    Leary SE, Eley SM, Williamson ED, Titball RW.
    Contrib Microbiol Immunol; 1995 Jan 22; 13():216-7. PubMed ID: 8833838
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
    Wang S, Goguen JD, Li F, Lu S.
    Vaccine; 2011 Sep 09; 29(39):6802-9. PubMed ID: 21199697
    [Abstract] [Full Text] [Related]

  • 11. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
    Gupta G, Khan AA, Rao DN.
    Scand J Immunol; 2010 Mar 09; 71(3):186-98. PubMed ID: 20415784
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM.
    FEMS Immunol Med Microbiol; 2012 Aug 09; 65(3):505-9. PubMed ID: 22515653
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED, Flick-Smith HC, Waters E, Miller J, Hodgson I, Le Butt CS, Hill J.
    Microb Pathog; 2007 Jan 09; 42(1):11-21. PubMed ID: 17107769
    [Abstract] [Full Text] [Related]

  • 14. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.
    Morton M, Garmory HS, Perkins SD, O'Dowd AM, Griffin KF, Turner AK, Bennett AM, Titball RW.
    Vaccine; 2004 Jun 30; 22(20):2524-32. PubMed ID: 15193377
    [Abstract] [Full Text] [Related]

  • 15. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K, Meyers JL, Rogers TE, Fast RL, Bassett AD, Worsham PL, Powell BS, Norris SL, Krieg AM, Adamovicz JJ.
    Vaccine; 2009 Apr 06; 27(16):2220-9. PubMed ID: 19428836
    [Abstract] [Full Text] [Related]

  • 16. N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection.
    Hill J, Leary S, Smither S, Best A, Pettersson J, Forsberg A, Lingard B, Lipka A, Brown KA, Williamson ED, Titball RW.
    Vaccine; 2009 Nov 23; 27(50):7073-9. PubMed ID: 19786138
    [Abstract] [Full Text] [Related]

  • 17. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
    Elvin SJ, Williamson ED.
    Microb Pathog; 2004 Oct 23; 37(4):177-84. PubMed ID: 15458778
    [Abstract] [Full Text] [Related]

  • 18. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
    Palin A, Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK.
    Vaccine; 2007 Jan 08; 25(4):741-50. PubMed ID: 16959385
    [Abstract] [Full Text] [Related]

  • 19. Immunisation against plague by transcutaneous and intradermal application of subunit antigens.
    Eyles JE, Elvin SJ, Westwood A, Lebutt CS, Alpar HO, Somavarapu S, Williamson ED.
    Vaccine; 2004 Oct 22; 22(31-32):4365-73. PubMed ID: 15474730
    [Abstract] [Full Text] [Related]

  • 20. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.
    Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ.
    Biotechnol Prog; 2005 Oct 22; 21(5):1490-510. PubMed ID: 16209555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.